Skip to main content
. 2018 Oct 7;23(10):2554. doi: 10.3390/molecules23102554

Table 3.

Activity of compounds against hospital methicillin-susceptible strains of S. aureus (MSSA), methicillin-resistant strains of S. aureus (MRSA) and S. epidermidis (MRSE)—minimal inhibitory concentrations (MIC, µg/mL).

S. aureus MSSA 440/11 441/11 442/11 443/11 444/11 445/11 446/11 447/11 448/11 449/11
6 6.25 6.25 6.25 6.25 6.25 6.25 6.25 6.25 6.25 6.25
14 25 25 25 25 12,5 25 25 25 25 25
Ciprofloxacin 0.4 0.4 0.4 0.4 0.8 0.4 0.4 0.8 0.8 0.4
S. aureus MRSA 389/10 390/10 391/10 392/10 393/10 394/10 399/10 450/11 451/11 452/11
6 6.25 6.25 6.25 6.25 6.25 6.25 6.25 6.25 6.25 6.25
14 25 25 25 25 25 25 25 25 25 25
Ciprofloxacin 25 100 100 100 50 25 200 100 100 200
S. epidermidis MRSE 430/11 431/11 432/11 433/11 434/11 435/11 436/11 437/11 438/11 439/11
6 6.25 6.25 6.25 6.25 12.5 6.25 6.25 6.25 6.25 6.25
14 25 6.25 25 25 25 25 50 25 50 25
15 400 50 50 50 50 100 100 100 200 50
19 12.5 100 12.5 50 12.5 50 100 200 100 50
Ciprofloxacin 0.8 6.25 50 50 50 0.4 0.4 0.8 0.4 50